Federal judge blocks Kennedy's vaccine agenda; $92M HIV drug fraud; 1 in 3 Americans cutting costs for care — Morning Medical Update Weekly Recap

Federal judge blocks Kennedy's childhood vaccine overhaul, suspends ACIP panel

Court rules CDC lacked authority to revise immunization schedule without advisory committeeRuling invalidates 2025 ACIP votes, postpones this week's scheduled meeting.

A federal judge dealt a major blow to Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.'s vaccine agenda Monday, blocking the revised childhood immunization schedule issued in January and suspending all 13 of Kennedy's appointees to the Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP).

U.S. District Judge Brian Murphy granted a preliminary injunction sought by the American Academy of Pediatrics (AAP) and other medical organizations, finding the CDC lacked authority to unilaterally reduce routinely recommended childhood vaccines from 17 to 11 without ACIP's formal involvement — a problem because multiple federal statutes, including the ACA and Medicaid, explicitly tie insurance coverage requirements to ACIP recommendations. Murphy also found the reconstituted committee likely violated federal law requiring advisory panels to be "fairly balanced" in expertise, noting at least six of the 15 current members lacked meaningful vaccine-related experience. The ruling also invalidates votes the Kennedy-appointed panel took in 2025, including moves to downgrade COVID-19 and hepatitis B recommendations, and forced the postponement of this week's scheduled ACIP meeting. HHS says it expects the ruling to be overturned on appeal. Read more here.

Maryland pharma brothers sentenced to 38 combined years for $92M black-market HIV drug scheme

Executives sourced diverted medications through patient buyback operations, resold with falsified paperworkAt least one patient lost consciousness after ingesting wrong drug from mislabeled bottle.

Two owners of a Maryland-based pharmaceutical wholesaler have been sentenced to a combined 38 years in prison for orchestrating a nationwide scheme that distributed more than $92 million worth of black-market HIV medications through the U.S. drug supply chain.

Prosecutors said the executives — brothers Patrick Boyd, 47, and Charles Boyd, 43, both of Easton, Maryland — sourced drugs through illegal patient “buyback” schemes, repackaged and resold them with falsified documentation, despite complaints from pharmacies about tampered bottles and incorrect medications. In some cases, patients received the wrong drugs, including one who lost consciousness after ingesting an antipsychotic medication mislabeled as HIV treatment.

Authorities said the scheme not only defrauded federal health programs but also endangered vulnerable patients and undermined the integrity of the pharmaceutical supply chain. The brothers were convicted on a number of charges at trial. Charles, the CEO, was sentenced to 20 years in prison, and Patrick, managing partner of the organization’s sales division, was sentenced to 18 years. The defendants were also ordered to forfeit over $21.8 million, and a third defendant, Adam Brosius, was sentenced to 97 months in prison in connection with his role in the scheme.

One in three Americans cut back on food or daily expenses to cover health care in 2025, survey finds

Cost burden extends well into insured population, West Health-Gallup data shows. Researchers warn declining health outcomes compounding financial strain.

A nationally representative survey of nearly 20,000 U.S. adults found that 33% made at least one trade-off in daily expenses, including food and utilities, to cover health care costs in 2025. According to new data from the West Health-Gallup Center, the burden was steepest among the uninsured, with 62% reporting sacrifices including borrowing money and skipping or stretching medications, but close to three in ten insured Americans reported making sacrifices as well.

A companion survey found health care costs are also reshaping major life decisions, with nearly 9% of respondents delaying retirement and roughly twice that share delaying a job change. Researchers noted the findings arrive alongside worsening health outcomes, with higher reported rates of metabolic disease, depression and anxiety.